Weight management
Tirzepatide
GIP/GLP-1 peptide · weekly injection
Tirzepatide is a peptide medication that acts on two hormone pathways, GIP and GLP-1, involved in appetite and blood-sugar regulation.
It’s taken as a weekly injection alongside changes to eating and activity. Your provider decides whether it’s appropriate and adjusts the dose over time.
- CategoryWeight management
- FormWeekly injection
- SourceD3 — brand-name via manufacturer program, or compounded by a licensed pharmacy
- PrescriptionRequired, after evaluation by a licensed provider
- PriceTo confirm
Prescription only. A licensed provider decides whether this treatment is appropriate for you; not everyone who completes a visit is a candidate.
If VitaRx offers a compounded version, it is prepared by a licensed pharmacy for an individual patient’s prescription. Compounded medications are not FDA-approved, have not been evaluated by the FDA for safety, effectiveness or quality, and are not the same as any brand-name product.
Important safety information
Tirzepatide products carry a boxed warning for risk of thyroid C-cell tumors and should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Full Important Safety Information from the prescribing label to be supplied before launch
Tell your provider about all your health conditions and the medicines you take. Seek emergency care for severe symptoms. VitaRx is not a pharmacy and does not manufacture medications.
How it works
From visit to delivery
Online visit
Answer questions about your health, history and goals.
Provider review
A licensed clinician reviews your answers and decides on next steps.
Pharmacy fulfilment
If prescribed, a licensed U.S. pharmacy fills and ships it.
Ongoing care
Check-ins and messaging with your care team as you go.